Precigen (PGEN) Shares Outstanding (Diluted Average) (2013 - 2026)

Precigen (PGEN) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $354.3 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $354.3 million, up 20.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $354.3 million (up 20.56% YoY), and the FY2025 annual result was $313.0 million, up 16.9% from the prior year.
• Shares Outstanding (Diluted Average) advanced to $354.3 million in Q1 2026 per PGEN's latest filing, from $313.0 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $354.3 million in Q1 2026 and troughed at $199.6 million in Q1 2022.
• A 5-year average of $256.8 million and a median of $249.2 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) rose 1.32% in 2022, then gained 23.85% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $200.4 million in 2022, then climbed by 22.05% to $244.5 million in 2023, then gained by 9.48% to $267.7 million in 2024, then rose by 16.9% to $313.0 million in 2025, then grew by 13.2% to $354.3 million in 2026.
• Business Quant data shows PGEN's Shares Outstanding (Diluted Average) at $354.3 million in Q1 2026, $313.0 million in Q4 2025, and $299.2 million in Q3 2025.